Stock KMDA KAMADA LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Kamada Ltd. TEL AVIV STOCK EXCHANGE

Equities

KMDA

IL0010941198

Pharmaceuticals

Business Summary

Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Sales per Business

ILS in Million2022Weight2023Weight Delta
Proprietary Products
81.0 %
345 79.3 % 426 81.0 % +23.52%
Distribution
19.0 %
90 20.7 % 100 19.0 % +11.08%

Sales per region

ILS in Million2022Weight2023Weight Delta
United States
51.7 %
-- 272 51.7 % -
Israel
22.0 %
108 24.8 % 115 22.0 % +7.25%
Latin America
9.1 %
38 8.7 % 48 9.1 % +25.66%
Canada
7.8 %
-- 41 7.8 % -
Europe
5.0 %
18 4.1 % 26 5.0 % +47.43%
Asia
4.3 %
15 3.5 % 23 4.3 % +47.29%
Others
0.1 %
1 0.2 % 1 0.1 % -43.50%

Managers

Managers TitleAgeSince
Amir London CEO
 Chief Executive Officer 55 09/13/09
David Tsur FOU
 Founder 73 13/90/13
Chaime Orlev DFI
 Director of Finance/CFO 53 31/17/31
Eran Nir COO
 Chief Operating Officer 51 01/16/01
Naveh Tov CTO
 Chief Tech/Sci/R&D Officer 60 01/16/01
Nir Livneh LAW
 General Counsel 45 01/10/01
Hanni Neheman SAM
 Sales & Marketing 54 01/14/01
Boris Gorelik PRN
 Corporate Officer/Principal - 01/20/01
Orit Pinchuk LAW
 General Counsel 59 01/14/01
Liron Reshef HRO
 Human Resources Officer - 01/23/01

Members of the board

Members of the board TitleAgeSince
Ishay Davidi BRD
 Director/Board Member 62 24/19/24
Leon Recanati BRD
 Director/Board Member 76 01/05/01
David Tsur FOU
 Founder 73 13/90/13
Lilach Asher Topilsky CHM
 Chairman 54 24/19/24
Assaf Itshayek BRD
 Director/Board Member 52 29/23/29
Lilach Payorski BRD
 Director/Board Member 51 16/21/16
Karnit Goldwasser BRD
 Director/Board Member 47 24/19/24
Benjamin Dekel BRD
 Director/Board Member - 29/23/29
Uri Botzer BRD
 Director/Board Member - 01/22/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 57,479,528 31,185,450 ( 54.25 %) 0 54.25 %

Shareholders

NameEquities%Valuation
First Israel Mezzanine Investors Ltd.
38.42 %
22,084,287 38.42 % 125 M ₪
Phoenix Investments House Ltd.
7.238 %
4,159,923 7.238 % 24 M ₪
Leon Recanati
6.070 %
3,488,886 6.070 % 20 M ₪
THE PHOENIX HOLDINGS LTD.
3.336 %
1,917,477 3.336 % 11 M ₪
Vanguard Fiduciary Trust Co.
2.130 %
1,224,226 2.130 % 7 M ₪
Renaissance Technologies LLC
1.493 %
858,363 1.493 % 5 M ₪
Wells Fargo Clearing Services LLC
1.128 %
648,516 1.128 % 4 M ₪
David Tsur
1.058 %
607,929 1.058 % 3 M ₪
Acadian Asset Management LLC
0.8954 %
514,641 0.8954 % 3 M ₪
THE PHOENIX HOLDINGS LTD.
0.3460 %
198,876 0.3460 % 1 M ₪

Company contact information

Kamada Ltd.

Science Park 2 Holzman Street

7670402, Rehovot

+

http://www.kamada.com
address Kamada Ltd.(KMDA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
CSL LIMITED Stock CSL Limited
-3.80% 86.85B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.76% 40.16B
BIOGEN INC. Stock Biogen Inc.
-16.48% 31.28B
UCB Stock UCB
+57.86% 25.27B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-13.58% 15.33B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.12% 11.96B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.56% 11.61B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+6.89% 8.83B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-6.32% 7.94B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. KMDA Stock
  4. KMDA Stock
  5. Company Kamada Ltd.